Showing results (81-90 of 114) with videos related to
Sort By:
Pageof 12
Oncology Research|February 26, 2020
A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell LymphomaQiuyun Luo, Wentao Pan, Suna Zhou, et al.Current Cancer Drug Targets|April 8, 2010
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, A Aboukameel, et al.Gels (Basel, Switzerland)|February 26, 2026
Unravelling the Deterioration Mechanism of the Coated Tofu Gel During Cold Storage: The Role of Protein OxidationSaihua Sun, Xiaohu Zhou, Yang Liu, et al.Journal of Medicinal Chemistry|April 30, 2004
Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure databaseZaneta Nikolovska-Coleska, Liang Xu, Zengjian Hu, et al.Gels (Basel, Switzerland)|May 27, 2026
Metal-Phenolic Networks Delay the Oxidation of Alkaline High-Protein Gel Foods: Improving the Quality of Coated TofuJian Zeng, Xiaohu Zhou, Yang Liu, et al.Journal of Cancer|April 15, 2016
Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic ValueMiaozhen Qiu, Huijuan Qiu, Ying Jin, et al.Cancer Biology & Therapy|September 5, 2008
Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivoYuan Sun, Jack Wu, Amro Aboukameel, et al.Cancer Cell International|May 24, 2024
Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cellsWentao Pan, Qiuyun Luo, Eric Liang, et al.Journal of Medicinal Chemistry|June 10, 2026
Discovery of an Indole-Based p53-Y220C Reactivator with In Vivo Antitumor Activity via Structure-Guided DesignYule Ma, Xiaoning Zhu, Jiahao Yuan, et al.Oncotarget|May 13, 2017
Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cellsHaibo Chen, Dingyuan Luo, Lin Zhang, et al.Pageof 12